Speaker illustration

Doctor Kazuo Komamura

IUHW Atami Hospital, Atami (Japan)

Member of:

European Society of Cardiology
Heart Failure Association

Recombinant insulin-like growth factor-1 improves cardiac function and symptoms in the patients on the waiting list for heart transplantation with end-stage dilated cardiomyopathy

Event: ESC Congress 2017

Topic: Drug therapy

Session: Inflammation, diabetes and their influence on the heart


Anticholinergic bronchodilator improves both pulmonary and cardiac functions in patients with heart failure with reduced ejection fraction complicated with chronic obstructive pulmonary disease.

Event: ESC Congress 2017

Topic: Pharmacologic therapy

Session: Chronic heart failure (CHF)


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb